Valuation: Olympus Corporation

Market Cap 1,856B 11.46B 10.01B 9.26B 8.55B 16.1B 1,101B 16.4B 110B 43.31B 539B 43.04B 42.09B P/E 2027 *
19.2x
P/E 2028 * 16x
Enterprise Value 1,925B 11.89B 10.39B 9.6B 8.87B 16.71B 1,142B 17.01B 115B 44.94B 559B 44.66B 43.67B EV / Sales 2027 *
1.81x
EV / Sales 2028 * 1.72x
Free-Float
94.53%
Yield 2027 *
1.76%
Yield 2028 * 1.85%
1 day-2.62%
1 week-2.40%
Current month+2.83%
1 month+2.58%
3 months+10.22%
6 months-17.30%
Current year-11.97%
1 week 1,729.5
Extreme 1729.5
1,817
1 month 1,610
Extreme 1610
1,818
Current year 1,302.5
Extreme 1302.5
2,137
1 year 1,302.5
Extreme 1302.5
2,168
3 years 1,302.5
Extreme 1302.5
2,867
5 years 1,302.5
Extreme 1302.5
3,198
10 years 758.75
Extreme 758.75
3,198
Manager TitleAgeSince
Chief Executive Officer 63 01/06/2025
Director of Finance/CFO 59 01/04/2026
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 69 01/04/2023
Director/Board Member 41 01/06/2019
Director/Board Member 63 01/06/2019
Change 5-day change 1-year change 3-year change Capi.($)
-2.62%-2.40%+4.30%-21.66% 11.77B
+0.61%+5.42%+28.65%+2.38% 198B
+3.33%-5.74%-23.62%+10.58% 134B
+0.89%+5.32%+4.18%-15.49% 141B
+1.91%-2.77%-57.90%-17.18% 63.36B
-1.68%-5.53%+15.17%-4.52% 51.87B
+1.36%+1.58%-24.66%-32.45% 43.77B
+0.61%+5.44%+20.50%+15.09% 38.18B
+0.58%+3.05%+31.01%+40.58% 36.96B
+2.38%-2.03%-14.81%-21.95% 28.05B
Average +0.71%-2.14%-1.72%-4.46% 74.77B
Weighted average by Cap. +1.13%-1.99%+0.94%-2.44%

Financials

2027 *2028 *
Net sales 1,065B 6.58B 5.75B 5.31B 4.91B 9.24B 632B 9.41B 63.37B 24.86B 309B 24.71B 24.16B 1,107B 6.83B 5.97B 5.52B 5.1B 9.6B 656B 9.78B 65.82B 25.83B 321B 25.66B 25.1B
Net income 98.47B 608M 531M 491M 454M 855M 58.4B 870M 5.86B 2.3B 28.6B 2.28B 2.23B 118B 726M 634M 586M 542M 1.02B 69.72B 1.04B 6.99B 2.74B 34.14B 2.73B 2.67B
Net Debt 69.9B 432M 377M 349M 322M 607M 41.46B 618M 4.16B 1.63B 20.3B 1.62B 1.59B 51.9B 320M 280M 259M 239M 450M 30.78B 459M 3.09B 1.21B 15.07B 1.2B 1.18B
Logo Olympus Corporation
Olympus Corp is a Japan-based company mainly engaged in the manufacture and sale of endoscopes, therapeutic equipment, scientific and other products. The Company operates through three business segments. The Endoscope segment provides gastrointestinal endoscopes, surgical endoscopes, and medical services. The Therapeutic Equipment segment provides gastrointestinal treatment instruments, urology products, respiratory products, energy devices, otolaryngology products and gynecology products. The Others segment provides biomaterials and orthopedic instruments. The Company is also engaged in the business activities, including holding companies and financial investments related to each business.
Employees
28,138
Date Price Change Volume
15/07/26 JP¥1,747.00 -2.62% 3,274,100
14/07/26 JP¥1,794.00 +1.04% 3,904,800
13/07/26 JP¥1,775.50 +1.25% 3,629,900
10/07/26 JP¥1,753.50 +0.72% 3,945,500
09/07/26 JP¥1,741.00 -1.64% 3,166,800
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
1,747.00JPY
Average target price
1,913.08JPY
Spread / Average Target
+9.51%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 7733 Stock